Profile data is unavailable for this security.
About the company
Nyrada Inc. is a preclinical stage, drug development company specializing in small molecule drugs to treat cardiovascular and neurological diseases. The Company’s two lead programs are focused on cholesterol-lowering and brain injury. These programs are developing an oral, small molecule cholesterol-lowering drug, and a drug to reduce secondary brain damage following a stroke or traumatic brain injury (TBI). Its Cholesterol-Lowering Program is an oral PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs. Its Brain Injury Program is developing a drug to block secondary brain damage that occurs following a stroke or TBI, such as severe head trauma from contact sports, a fall, or a motor vehicle accident. The Brain Injury Program is a neuroprotectant drug to reduce the impact of long-term disability in patients who suffer a traumatic brain injury or ischemic stroke. It is also developing new therapies.
- Revenue in AUD (TTM)3.08m
- Net income in AUD-4.98m
- Incorporated2017
- Employees--
- LocationNyrada IncSuite 2, Level 3,, 828 Pacific HighwayGORDON 2072AustraliaAUS
- Phone+61 29053-1990
- Fax+61 29053-1999
- Websitehttps://www.nyrada.com/site/content/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hydration Pharmaceuticals Co Ltd | 14.93m | -12.04m | 2.74m | -- | -- | -- | -- | 0.1839 | -0.0618 | -0.0618 | 0.0765 | -0.002 | 1.18 | 1.61 | 6.60 | -- | -94.86 | -79.98 | -143.75 | -111.57 | 53.70 | 48.73 | -80.69 | -99.53 | 1.37 | -21.48 | 1.10 | -- | 10.34 | 19.27 | 23.61 | -- | -- | -- |
Epsilon Healthcare Ltd | 7.21m | -5.93m | 7.21m | -- | -- | 0.7868 | -- | 0.9994 | -0.0198 | -0.0198 | 0.0241 | 0.0305 | 0.3839 | 17.94 | 2.73 | -- | -31.54 | -35.68 | -46.30 | -41.11 | 37.99 | 26.88 | -82.17 | -197.56 | 0.5237 | -9.28 | 0.2329 | -- | 29.36 | 30.99 | -43.77 | -- | 8.14 | -- |
Anatara Lifesciences Ltd | 0.00 | -1.75m | 7.65m | -- | -- | 5.30 | -- | -- | -0.014 | -0.014 | 0.00 | 0.0076 | 0.00 | -- | -- | -- | -103.15 | -59.64 | -115.72 | -66.52 | -- | -- | -- | -1,927.05 | -- | -- | 0.00 | -- | -- | -- | 20.10 | -- | -40.49 | -- |
Nyrada Inc | 3.08m | -4.98m | 10.20m | -- | -- | 1.91 | -- | 3.31 | -0.0319 | -0.0319 | 0.0198 | 0.0294 | 0.3983 | -- | -- | -- | -64.37 | -64.90 | -71.93 | -84.66 | -- | -- | -161.62 | -380.62 | -- | -15,086.39 | 0.00 | -- | 42.54 | 229.09 | -96.52 | -- | -- | -- |
TrivarX Ltd | 20.81k | -3.74m | 10.24m | 4.00 | -- | 1.01 | -- | 492.13 | -0.0182 | -0.0182 | 0.00009 | 0.0249 | 0.0023 | -- | -- | -- | -42.02 | -41.56 | -47.15 | -50.51 | 100.00 | 92.74 | -17,949.78 | -334.16 | -- | -147.21 | 0.0072 | -- | -4.69 | -18.06 | 75.85 | -- | -- | -- |
Firebrick Pharma Ltd | 0.00 | -4.57m | 10.35m | -- | -- | 5.94 | -- | -- | -0.0266 | -0.0266 | 0.00 | 0.0089 | 0.00 | -- | -- | -- | -120.70 | -- | -136.04 | -- | -- | -- | -- | -- | 4.37 | -- | 0.00 | -- | -79.85 | -- | -79.18 | -- | -- | -- |
Althea Group Holdings Ltd | 28.70m | -20.99m | 10.54m | -- | -- | 0.6874 | -- | 0.3672 | -0.059 | -0.059 | 0.0796 | 0.0378 | 0.6181 | 2.47 | 5.53 | -- | -45.22 | -31.09 | -66.73 | -36.32 | 54.64 | 50.76 | -73.15 | -101.39 | 0.4899 | -46.55 | 0.2756 | -- | 22.43 | 335.18 | -13.21 | -- | -- | -- |
Argent BioPharma Ltd | 1.32m | -17.02m | 13.13m | -- | -- | 7.81 | -- | 9.91 | -3.32 | -3.32 | 0.1003 | 0.0372 | 0.0813 | 0.7078 | 1.58 | -- | -105.32 | -111.29 | -345.98 | -171.05 | 21.87 | 32.52 | -1,295.20 | -632.42 | 0.6561 | -24.85 | 0.4104 | -- | -28.41 | 47.31 | -2.34 | -- | -16.20 | -- |
Auscann Group Holdings Ltd | 2.05m | -9.44m | 17.51m | 27.00 | -- | -- | -- | 8.55 | -0.0213 | -0.0217 | 0.0043 | 0.0162 | 0.1674 | -- | 5.35 | -- | -77.15 | -39.85 | -78.72 | -40.73 | 100.59 | -- | -460.74 | -925.91 | -- | -23.16 | 0.00 | -- | 13.88 | 51.37 | 57.10 | -- | -- | -- |
Acrux Ltd | 14.46m | -709.00k | 18.32m | 43.00 | -- | 3.24 | -- | 1.27 | -0.0024 | -0.0024 | 0.0502 | 0.0195 | 1.29 | -- | 4.86 | -- | -6.34 | -39.91 | -9.21 | -46.00 | 72.38 | -- | -4.90 | -132.53 | -- | -- | 0.2861 | -- | 133.74 | 28.29 | 92.23 | -- | -16.66 | -- |
Calmer Co International Ltd | 2.46m | -4.50m | 18.38m | -- | -- | -- | -- | 7.47 | -0.0083 | -0.0083 | 0.0039 | -0.0005 | 0.655 | 1.34 | 9.62 | -- | -119.81 | -139.15 | -231.33 | -198.55 | 36.03 | 30.26 | -182.94 | -388.81 | 0.482 | -9.36 | 1.22 | -- | -13.00 | 239.43 | 11.40 | -- | -- | -- |
Oncosil Medical Ltd | 355.30k | -11.71m | 19.99m | 2.00 | -- | 3.07 | -- | 56.27 | -0.0081 | -0.0081 | 0.0002 | 0.002 | 0.0506 | -- | 7.88 | -- | -166.55 | -57.65 | -234.81 | -64.83 | -426.96 | -- | -3,295.08 | -473.02 | -- | -68.93 | 0.0256 | -- | -59.92 | -37.72 | -5.74 | -- | 40.13 | -- |
Immuron Ltd | 3.58m | -3.88m | 20.06m | 6.00 | -- | 1.14 | -- | 5.61 | -0.017 | -0.017 | 0.0157 | 0.0769 | 0.1664 | 0.6468 | 7.92 | 596,106.70 | -18.06 | -27.48 | -19.86 | -29.58 | 80.87 | 77.52 | -108.52 | -296.64 | 7.79 | -2.85 | 0.0023 | -- | 135.85 | -13.34 | -32.66 | -- | 3.27 | -- |